phenylalanine has been researched along with Carcinoma, Neuroendocrine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balakrishna, P; George, S; Hatoum, H; Mukherjee, S | 1 |
| Cote, G; Grubbs, EG; Habra, MA; Hu, MI; Jasim, S; Jimenez, C; Rich, TA; Waguespack, SG; Ying, AK | 1 |
1 review(s) available for phenylalanine and Carcinoma, Neuroendocrine
| Article | Year |
|---|---|
Serotonin Pathway in Cancer.
Topics: Antineoplastic Agents, Hormonal; Carcinoma, Neuroendocrine; Cell Movement; Cell Proliferation; Cholangiocarcinoma; Gene Expression Regulation, Neoplastic; Humans; Molecular Targeted Therapy; Neovascularization, Pathologic; Octreotide; Phenylalanine; Pyrimidines; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Signal Transduction; Tryptophan Hydroxylase; Tumor Cells, Cultured | 2021 |
1 other study(ies) available for phenylalanine and Carcinoma, Neuroendocrine
| Article | Year |
|---|---|
Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Alanine; Carcinoma, Neuroendocrine; Female; Germ-Line Mutation; Humans; Methionine; Multiple Endocrine Neoplasia Type 2b; Phenylalanine; Pheochromocytoma; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Risk Factors; Threonine; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome | 2011 |